| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |